Corporate Profile

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.

The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital ... More >>

Stock Quote

CSII (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 0.18 (0.78%)
Data as of 09/04/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Upcoming Events

More >>
Wednesday, September 16, 2015 12:30 p.m. ET
Cardiovascular Systems, Inc. at Morgan Stanley Global Healthcare Conference
Add to Calendar Add Cardiovascular Systems, Inc. at Morgan Stanley Global Healthcare Conference  to Calendar  Help
remind me days before the event

Enter your e-mail address 

Recent News

More >>
Cardiovascular Systems to Participate in Morgan Stanley Global Healthcare Conference
ST. PAUL, Minn.--(BUSINESS WIRE)--Sep. 2, 2015-- Cardiovascular Systems (NASDAQ:CSII) will attend the Morgan Stanley Global Healthcare Conference on Wednesday, September 16, 2015. President and Chief Executive Officer, David L. Martin, will participate in a fireside chat at 12:30 p.m. Eastern Time. You may access the live audio webcast and presentation materials in the Investors section at: Presentation materials also will ... 
Peripheral Arterial Disease: A Disease Marked by Leg Pain and Wounds on Legs and Feet
Cardiovascular Systems Urges Greater Awareness During September PAD Awareness Month ST. PAUL, Minn.--(BUSINESS WIRE)--Aug. 31, 2015-- September marks peripheral arterial disease (PAD) awareness month. A staggering 18 million Americans1 suffer from this potentially life threatening disease which is greater than the number of Americans suffering from stroke (6.8 million)2, cancer (13 million)3, and coronary artery disease (16.3 million)4. If unt... 
Cardiovascular Systems Reports Fiscal 2015 Fourth-Quarter Financial Results
Conference Call Scheduled for Today, August 5, 2015, at 3:45 PM CT (4:45 PM ET) Revenues grew to $48.5 million, a 22 percent increase over the fourth quarter of fiscal 2014 Full-year fiscal 2015 revenues grew 33 percent, the second consecutive year of revenue growth in excess of 30 percent FDA clears 4 French Diamondback 360® device and next-generatio... 
Cardiovascular Systems to Webcast Fiscal 2015 Fourth-Quarter Earnings Conference Call Wednesday, August 5
Live Webcast at 3:45 p.m. CT (4:45 p.m. ET) ST. PAUL, Minn.--(BUSINESS WIRE)--Jul. 15, 2015-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2015 fourth-quarter conference call on Wednesday, August 5, 2015, at 3:45 p.m. CT (4:45 p.m. ET). David Martin, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss the company’s results for its fiscal fourth quarter en... 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.